Cargando…

New Approaches to Treating Alzheimer’s Disease

To date, no truly efficacious drugs for Alzheimer’s disease (AD) have been developed; moreover, all new anti-AD drugs developed since 2003 have failed. To succeed where previous ones have failed in drug development, new approaches for AD therapy are needed. Here we discuss the potential application...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hailin, Fridkin, Mati, Youdim, Moussa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327405/ https://www.ncbi.nlm.nih.gov/pubmed/25733799 http://dx.doi.org/10.4137/PMC.S13210

Ejemplares similares

From Single Target to Multitarget/Network Therapeutics in Alzheimer’s Therapy
por: Zheng, Hailin, et al.
Publicado: (2014)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
por: Youdim, Moussa B. H.
Publicado: (2010)

To treat or not to treat Alzheimer’s disease by the ketogenic diet? That is the question
por: Ułamek-Kozioł, Marzena, et al.
Publicado: (2019)

Hyperbaric oxygen therapy as a new treatment approach for Alzheimer’s disease
por: Shapira, Ronit, et al.
Publicado: (2018)

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Neuroprotection and Neuroregeneration in Alzheimer's Disease
por: Sugaya, Kiminobu, et al.
Publicado: (2012)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?
por: Youdim, Moussa B. H.
Publicado: (2010)

The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
por: Kupershmidt, Lana, et al.
Publicado: (2023)

Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013)

Turning up the NAD(+)-mitophagy axis to treat Alzheimer’s disease
por: Fang, Evandro F., et al.
Publicado: (2022)

Dual targeting nano-approaches for Alzheimer's disease etiology
por: Hettiarachchi, Sajini D., et al.
Publicado: (2020)

Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease
por: Fessel, Jeffrey
Publicado: (2020)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

The challenges of the COVID‐19 pandemic: Approaches for the elderly and those with Alzheimer's disease
por: Zhang, Qing, et al.
Publicado: (2020)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease)
por: Dreves, Maria A. E., et al.
Publicado: (2023)

Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
por: Grossmann, Klaus
Publicado: (2021)

Myelin lipid deficiency: a new key driver of Alzheimer’s disease
por: Qiu, Shulan, et al.
Publicado: (2022)

Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
por: Fessel, Jeffrey
Publicado: (2019)

New Surgical Approach to Treat Fibroids and Solid Tumors – Thermal and Nonthermal Ablation
por: Wong, Wu-Shun Felix
Publicado: (2023)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
por: Bobkova, Natalia, et al.
Publicado: (2015)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Microglial metabolic reconfiguration provides a new strategy for the treatment of Alzheimer’s disease
por: Leng, Lige, et al.
Publicado: (2023)

Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research
por: Britton, Gabrielle B., et al.
Publicado: (2023)

Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer's disease
por: Alexander, Amit, et al.
Publicado: (2018)

Stem cell-derived three-dimensional (organoid) models of Alzheimer’s disease: a precision medicine approach
por: Kim, Sujung Jun, et al.
Publicado: (2021)

Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Prothrombin kringle-2, a mediator of microglial activation: new insight in Alzheimer’s disease pathogenesis
por: Lee, Jae Man, et al.
Publicado: (2022)

Beta‐amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease
por: Pannuzzo, Martina
Publicado: (2021)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Alzheimer’s Disease is a Disorder of Consciousness
por: Yokoi, Teruo
Publicado: (2023)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Reevaluating the cause of laminopathy in Alzheimer’s disease
por: Islam, Md Imamul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95bmotpr9ecgdlvhtqprv8s0ho